Analyst Price Targets — CTVA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 14, 2026 12:01 pm | — | Mizuho Securities | $97.00 | $85.72 | TheFly | Corteva price target raised to $97 from $96 at Mizuho |
| July 2, 2026 1:37 pm | — | Mizuho Securities | $96.00 | $85.25 | TheFly | Corteva price target raised to $96 from $94 at Mizuho |
| June 11, 2026 9:23 am | Benjamin Theurer | Barclays | $91.00 | $74.46 | TheFly | Corteva price target raised to $91 from $84 at Barclays |
| June 9, 2026 11:12 am | Joshua Spector | UBS | $86.00 | $75.86 | TheFly | Corteva price target lowered to $86 from $90 at UBS |
| May 28, 2026 10:41 am | Vincent Andrews | Morgan Stanley | $95.00 | $79.89 | TheFly | Corteva price target raised to $95 from $84 at Morgan Stanley |
| April 24, 2026 12:10 pm | Arun Viswanathan | RBC Capital | $95.00 | $78.62 | TheFly | Corteva price target raised to $95 from $89 at RBC Capital |
| April 21, 2026 10:31 am | — | Wells Fargo | $90.00 | $80.29 | TheFly | Corteva price target raised to $90 from $85 at Wells Fargo |
| April 9, 2026 12:15 pm | — | UBS | $88.00 | $83.56 | TheFly | Corteva price target raised to $88 from $80 at UBS |
| February 17, 2026 12:04 pm | — | Mizuho Securities | $82.00 | $75.03 | TheFly | Corteva price target raised to $82 from $80 at Mizuho |
| February 9, 2026 5:50 am | Joshua Spector | UBS | $80.00 | $72.60 | StreetInsider | UBS Downgrades Corteva Inc. (CTVA) to Neutral |
Latest News for CTVA
The partnership will help farmers in Europe improve nutrient use efficiency The partnership will help farmers in Europe improve nutrient use efficiency
Karen Grimes to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today the board of directors for Vylor Inc., the future publicly traded, advanced seed and genetics company that will result from the current company's planned separation. Karen Grimes will lead the board as Independent Chair.
Greg Page to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today its intended board of directors as a standalone publicly-traded, differentiated crop protection company upon its planned separation in the fourth quarter of 2026. Greg Page will lead the nine-person board as Independent Chair as previously announced.
BG, DE and NTR are tapping AgTech and food innovation trends through smarter farming, crop nutrition and sustainable food solutions.
FMC's rimisoxafen deal with Corteva aims to expand access to dual-mode herbicide technology for corn and soybean markets across the Americas.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.